SPARC and neoplasm: Chlenski et al (62) reported that in addition to stromal formation enhancement, SPARC prevented fibroblast activation in 293 xenografts, indicating that the anticancer effects of SPARC may be due to the formation of tumor stroma, which do not support tumor growth (56).